Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of $48.88 billion as of January 13, 2026. Its market cap has increased by 55.78% in one year.

• Market Cap: 48.88B
• Enterprise Value: 48.93B
• 1-Year Change: 55.78%
• Ranking: #310
• Category: Large-Cap
• Stock Price: $369.96

Market Cap Chart

Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $48.88B, an increase of 36,105.06%. That is a compound annual growth rate of 31.31%.

Market Cap History

Date	Market Cap	% Change
Jan 12, 2026	49.00B	-6.72%
Dec 31, 2025	52.54B	73.09%
Dec 31, 2024	30.35B	26.35%
Dec 29, 2023	24.02B	-17.84%
Dec 30, 2022	29.24B	44.16%
Dec 31, 2021	20.28B	34.32%
Dec 31, 2020	15.10B	17.60%
Dec 31, 2019	12.84B	74.32%
Dec 31, 2018	7.37B	-37.48%
Dec 29, 2017	11.78B	266.69%
Dec 30, 2016	3.21B	-59.72%
Dec 31, 2015	7.98B	6.90%
Dec 31, 2014	7.46B	82.96%
Dec 31, 2013	4.08B	326.36%
Dec 31, 2012	956.60M	174.73%
Dec 30, 2011	348.20M	-16.32%
Dec 31, 2010	416.10M	-43.53%
Dec 31, 2009	736.80M	-28.05%
Dec 31, 2008	1.02B	-13.48%
Dec 31, 2007	1.18B	71.64%
Dec 29, 2006	689.60M	94.42%
Dec 30, 2005	354.70M	136.47%
Dec 31, 2004	150.00M	11.11%
Jun 1, 2004	135.00M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	964.49B
Johnson & Johnson	514.75B
AbbVie	390.15B
UnitedHealth Group	302.49B
AstraZeneca	291.77B
Novartis AG	272.12B
Merck & Co.	268.70B
Novo Nordisk	265.30B